Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Prevot

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Progress in Clinical and Biological Research|January 1, 1990
Recombinant alpha-interferon plus vinblastine in metastatic renal-cell cancer: analysis of response and survival in 58 evaluable patientsJ P Bergerat, J Ford, R Herbrecht, et al.
Cancer|December 1, 1988
Combination of recombinant interferon alpha-2a and vinblastine in advanced renal cell cancerJ P Bergerat, R Herbrecht, P Dufour, et al.
Presse Medicale (Paris, France : 1983)|November 21, 1987
[Treatment of metastatic renal adenocarcinomas with combined recombinant alpha-2a interferon and vinblastine]J P Bergerat, P Dufour, Y Soyer, et al.
Presse Medicale (Paris, France : 1983)|March 20, 1993
[Cancer of the breast in men. 106 cases]B F Cutuli, M Velten, P Forentz, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Prognostic factors in ovarian carcinoma in complete histologic remission at second-look surgeryD. Hamid, B. Duclos, J. C. Barats, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 12, 2000
[Concurrent split-course chemotherapy and radiotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a Phase II study]M Benchalal, P Salze, P Bombaron, et al.
Data in Brief|April 25, 2023
Dataset of night-time emissions of the Earth in the near UV range (290-430 nm), with 6.3 km resolution in the latitude range -51.6<L<+51.6 degrees, acquired on board the International Space Station with the Mini-EUSO detectorL Marcelli, K Bolmgren, D Barghini, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Progress in Clinical and Biological Research|January 1, 1990
Recombinant alpha-interferon plus vinblastine in metastatic renal-cell cancer: analysis of response and survival in 58 evaluable patientsJ P Bergerat, J Ford, R Herbrecht, et al.
Cancer|December 1, 1988
Combination of recombinant interferon alpha-2a and vinblastine in advanced renal cell cancerJ P Bergerat, R Herbrecht, P Dufour, et al.
Presse Medicale (Paris, France : 1983)|November 21, 1987
[Treatment of metastatic renal adenocarcinomas with combined recombinant alpha-2a interferon and vinblastine]J P Bergerat, P Dufour, Y Soyer, et al.
Presse Medicale (Paris, France : 1983)|March 20, 1993
[Cancer of the breast in men. 106 cases]B F Cutuli, M Velten, P Forentz, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Prognostic factors in ovarian carcinoma in complete histologic remission at second-look surgeryD. Hamid, B. Duclos, J. C. Barats, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 12, 2000
[Concurrent split-course chemotherapy and radiotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a Phase II study]M Benchalal, P Salze, P Bombaron, et al.
Data in Brief|April 25, 2023
Dataset of night-time emissions of the Earth in the near UV range (290-430 nm), with 6.3 km resolution in the latitude range -51.6<L<+51.6 degrees, acquired on board the International Space Station with the Mini-EUSO detectorL Marcelli, K Bolmgren, D Barghini, et al.
Pageof 3